These results demonstrate ENO1 and PGM2L1 prove malignant progression of PAAD by promoting the proliferative, migratory, invasive capacities and glycolytic activity of PAAD cells. The gene discussed is PGM2L1; the disease is pancreatic adenocarcinoma.